Skandinaviska Enskilda Banken AB publ Has $183.24 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Skandinaviska Enskilda Banken AB publ lessened its position in Colgate-Palmolive (NYSE:CL) by 1.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,888,244 shares of the company’s stock after selling 30,666 shares during the quarter. Colgate-Palmolive comprises about 0.9% of Skandinaviska Enskilda Banken AB publ’s investment portfolio, making the stock its 21st biggest position. Skandinaviska Enskilda Banken AB publ owned about 0.23% of Colgate-Palmolive worth $183,235,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AE Wealth Management LLC raised its stake in Colgate-Palmolive by 70.9% during the 2nd quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock valued at $2,194,000 after purchasing an additional 9,382 shares during the last quarter. King Luther Capital Management Corp raised its position in shares of Colgate-Palmolive by 0.3% during the second quarter. King Luther Capital Management Corp now owns 1,317,589 shares of the company’s stock valued at $127,859,000 after buying an additional 3,461 shares during the last quarter. Bridges Investment Management Inc. lifted its stake in shares of Colgate-Palmolive by 11.3% in the second quarter. Bridges Investment Management Inc. now owns 12,837 shares of the company’s stock valued at $1,246,000 after buying an additional 1,300 shares during the period. Canada Pension Plan Investment Board grew its position in Colgate-Palmolive by 38.8% during the second quarter. Canada Pension Plan Investment Board now owns 2,541,975 shares of the company’s stock worth $246,673,000 after buying an additional 710,500 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. lifted its position in shares of Colgate-Palmolive by 6.7% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 104,427 shares of the company’s stock worth $10,134,000 after acquiring an additional 6,554 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last 90 days. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $101.98 on Friday. The stock has a market cap of $83.67 billion, a price-to-earnings ratio of 32.27, a P/E/G ratio of 3.72 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The business’s 50-day simple moving average is $102.61 and its 200 day simple moving average is $95.65.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm’s quarterly revenue was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.77 EPS. As a group, research analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.96%. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent research reports. Evercore ISI increased their price objective on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Bank of America upped their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. Wells Fargo & Company cut Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price target on the stock. in a research report on Monday. Finally, BNP Paribas started coverage on Colgate-Palmolive in a report on Monday, June 24th. They set an “outperform” rating and a $109.00 price objective for the company. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $102.79.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.